The Europe antibody discovery market size was estimated at USD 2.63 billion in 2025 and is predicted to reach around USD 6.23 billion by 2035, expanding at a CAGR of 9% from 2026 to 2035. Growing due to expansion is supported by increasing government funding and a well-established biotechnology research ecosystem.

Europe Cancer Supportive Care Drugs Market Statical Scope

Long-term growth is being supported by the growing emphasis on biosimilars and next-generation antibody treatments. Additionally, the regions' capacity for antibody discovery is being strengthened by strategic alliances and international research projects.

The market is driven by an increased emphasis on cutting-edge antibody-based therapies and increased government funding for life sciences research. Additionally, growing partnerships between biotech companies and research institutions are improving development capabilities.

Europe Antibody Discovery Market Share, By Methods, 2025 (%)

• Phage Display - Phage display segment is dominating with a share of 46%, driven by technological advancements. Furthermore, a strong research infrastructure is supporting widespread adoption.
• Hybridoma - The hybridoma segment is notable with a share of 32%, driven by consistent research demand. Additionally, its long-standing application in antibody production sustains its presence.

Europe Antibody Discovery Market Share, By Antibody Type, 2025 (%)

• Humanized Antibody - Humanized antibody segment is dominating with a share of 34% driven by safer therapeutic profiles. Moreover, increasing focus on precision medicine is boosting its use.
• Human Antibody - Human antibody segment is notable with a share of 31% driven by increasing biologics adoption. In addition, rising approvals are supporting market expansion.
• Chimeric Antibody - The chimeric antibody segment holds a share of 20% driven by established clinical applications. Furthermore, ongoing demand in oncology treatments supports growth.
• Murine Antibody - The murine antibody segment holds a share of 15% driven by research applications. Additionally, it continues to play a role in early discovery stages.

Europe Antibody Discovery Market Share, By End User, 2025 (%)

• Pharmaceutical and Biotechnology Industry - The pharmaceutical and biotechnology industry segment is dominating with a share of 58% driven by strong pipeline development. Moreover, increasing investments in biologics are strengthening growth.
• Research Laboratory - Research laboratory segment is notable with a share of 24% driven by growing R&D activities. In addition, government funding initiatives are supporting expansion.
• Academic Laboratory - Academic laboratory segment holds a share of 18% driven by institutional research support. Furthermore, rising collaborations are enhancing innovation.

Top Companies in the Europe Antibody Discovery Market

• Danaher Corporation
• Eurofins Scientific
• Evotec
• Twist Bioscience
• Charles River Laboratories
• Genscript Technology Corporation
• Biocytogen
• Sartorius AG
• Fairjourney Biologics S.A
• Creative Biolabs

Segments Covered in the Report

By Methods

• Phage Display
• Hybridoma
• Others

By Antibody Type

• Humanized Antibody
• Human Antibody
• Chimeric Antibody
• Murine Antibody

By End Users

• Pharmaceutical and Biotechnology industry
• Research laboratory
• Academic laboratory